Lapatinib moves forward in inflammatory and early HER2-positive breast cancer trials
- PMID: 17341725
- DOI: 10.1093/jnci/djk122
Lapatinib moves forward in inflammatory and early HER2-positive breast cancer trials
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
